The landscape of dementia prognosis has developed significantly with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based tests which will detect Alzheimer's pathology a long time prior to indications emerge. While these technological advancements symbolize remarkable progress in understanding neurodegenerative disorders, they'v... https://samirb975xhq4.wikipublicity.com/user